The delicate balance the body maintains to keep blood pressure stable involves not only the prostaglandin system, but another biological pathway, the renin-angiotensin-aldosterone system, or RAAS.

PATHWAY-2 uncovers main cause of drug-resistant hypertension, ... which included an angiotensin converting enzyme ... "Both spironolactone and amiloride block the effects of aldosterone ...

The use of angiotensin-converting enzyme (ACE) inhibitors and, more recently, angiotensin receptor blockers (ARBs) in the treatment of hypertension and CHF assume that aldosterone as well as ...

There is concern about the potential of an increased risk related to medications that act on the renin–angiotensin–aldosterone system in patients exposed to coronavirus disease 2019 (Covid-19 ...

Angiotensin II receptor antagonists are agents used to modify the renin-angiotensin-aldosterone system (RAAS) through blocking angiotensin receptors. This has the effect of lowering blood pressure.

BACKGROUND: Primary aldosteronism (PA), an overt form of renin-independent aldosterone production, leads to a disproportionately high rate of major adverse cardiovascular events (MACEs). Mounting ...

Discontinuing or reducing renin-angiotensin-aldosterone system inhibitor treatment may have negative outcomes for patients with hyperkalemia, but it is a common practice in many clinics, according ...

Angiotensin receptor blockers (ARBs) are a class of oral medications that act primarily through blockade of the angiotensin receptor. The effects of angiotensin include vasoconstriction and ...

The renin-angiotensin-aldosterone system (RAAS) in your body helps control your blood pressure and blood volume. It includes renin (an enzyme), and the hormones angiotensin II and aldosterone.

Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. Renin–angiotensin–aldosterone system inhibitors in patients with Covid-19. N Engl J Med 2020;382:1653-1659. Crossref.